5-10
2026
影响因子区间
—
平台估算
17%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:An essential resource for R&D professionals and clinicians with an interest in biologic therapies.BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
【译文】一本为对生物疗法感兴趣的R&D专业人士和临床医生提供的重要资源。BioDrugs涵盖了基于生物技术的药物和诊断产品的开发和治疗应用,用于治疗人类疾病。该期刊提供了一系列增强功能,旨在提高内容的可见性、阅读量和教育价值。每篇文章都附有要点总结,为广泛的读者提供内容的高效概述。文章可能还附有通俗易懂的摘要,以帮助患者、护理人员和他人理解重要的医学进展。该期刊还提供包括幻灯片集、视频和动画在内的各种其他增强功能。所有增强功能都经过与文章本身相同的高标准同行评审。同行评审使用Editorial Manager®进行,并支持一个国际专家数据库。该数据库与其他Adis期刊共享。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 2区 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |